Insulin resistance: A significant risk factor of endometrial cancer

Gynecologic Oncology

Volumn 125, Issue 3, 2012, Pages 751-757

  Mu, Nan ^a   Zhu, Yuanxi ^a   Wang, Yingmei ^a   Zhang, Huiying ^a   Xue, Fengxia ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Adipokine; Endometrial cancer; Insulin resistance; Obesity; PI3K Akt; Ras MAPK

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR; AROMATASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; ESTROGEN; INSULIN; INSULIN SENSITIZING AGENT; INTERLEUKIN 6; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

CANCER RISK; CELL MATURATION; CONFERENCE PAPER; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; ENZYME ACTIVATION; ENZYME INHIBITION; ESTROGEN SYNTHESIS; GENE EXPRESSION REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT;

ANIMALS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; INSULIN RESISTANCE; RISK FACTORS;

EID: 84861184739     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.03.032     Document Type: Conference Paper

References (107)

1. R. Siegel, E. Ward, O. Brawley, and A. Jemal Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin 61 2011 212 236
2. B.E. Henderson, R.K. Ross, M.C. Pike, and J.T. Casagrande Endogenous hormones as a major factor in human cancer Cancer Res 42 1982 3232 3239
3. T.J. Key, and M.C. Pike The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk Br J Cancer 57 1988 205 212
4. B.S. Saltzman, J.A. Doherty, and D.A. Hill Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors Am J Epidemiol 167 2008 607 614
5. S. Wild, T. Pierpoint, H. Jacobs, and P. McKeigue Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study Hum Fertil (Camb) 3 2000 101 105
6. I.F. Godsland Insulin resistance and hyperinsulinaemia in the development and progression of cancer Clin Sci (Lond) 118 2010 315 332
7. M.J. Gunter, D.R. Hoover, and H. Yu A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer Cancer Epidemiol Biomarkers Prev 17 2008 921 929
8. J.K. Burzawa, K.M. Schmeler, and P.T. Soliman Prospective evaluation of insulin resistance among endometrial cancer patients Am J Obstet Gynecol 204 355 2011 e1 e7
9. L.M. Berstein, J.O. Kvatchevskaya, and T.E. Poroshina Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer J Cancer Res Clin Oncol 130 2004 687 693
10. A. Lukanova, A. Zeleniuch-Jacquotte, and E. Lundin Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer Int J Cancer 108 2004 262 268
11. N.E. Allen, T.J. Key, and L. Dossus Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC) Endocr Relat Cancer 15 2008 485 497
12. W.H. Xu, C.E. Matthews, and Y.B. Xiang Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women Am J Epidemiol 161 2005 939 947
13. W.H. Xu, Y.B. Xiang, and W. Zheng Weight history and risk of endometrial cancer among Chinese women Int J Epidemiol 35 2006 159 166
14. V.M. Chia, P.A. Newcomb, A. Trentham-Dietz, and J.M. Hampton Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis Int J Gynecol Cancer 17 2007 441 446
15. E. Friberg, N. Orsini, C.S. Mantzoros, and A. Wolk Diabetes mellitus and risk of endometrial cancer: a meta-analysis Diabetologia 50 2007 1365 1374
16. E.J. Fearnley, L. Marquart, A.B. Spurdle, P. Weinstein, and P.M. Webb Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study Cancer Causes Control 21 2010 2303 2308
17. T. Bjorge, T. Stocks, and A. Lukanova Metabolic syndrome and endometrial carcinoma Am J Epidemiol 171 2010 892 902
18. Y. Zhang, Z. Liu, and X. Yu The association between metabolic abnormality and endometrial cancer: a large case-control study in China Gynecol Oncol 117 2010 41 46
19. D. Haidopoulos, M. Simou, and N. Akrivos Risk factors in women 40 years of age and younger with endometrial carcinoma Acta Obstet Gynecol Scand 89 2010 1326 1330
20. P.T. Soliman, J.C. Oh, and K.M. Schmeler Risk factors for young premenopausal women with endometrial cancer Obstet Gynecol 105 2005 575 580
21. K.M. Schmeler, P.T. Soliman, C.C. Sun, B.M. Slomovitz, D.M. Gershenson, and K.H. Lu Endometrial cancer in young, normal-weight women Gynecol Oncol 99 2005 388 392
22. Y. Wang, F. Xue, R.R. Broaddus, X. Tao, S.S. Xie, and Y. Zhu Clinicopathological features in endometrial carcinoma associated with Lynch syndrome in China Int J Gynecol Cancer 19 2009 651 656
23. H. Xu, G.T. Barnes, and Q. Yang Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J Clin Invest 112 2003 1821 1830
24. N. Hosogai, A. Fukuhara, and K. Oshima Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation Diabetes 56 2007 901 911
25. G.S. Hotamisligil Inflammatory pathways and insulin action Int J Obes Relat Metab Disord 27 Suppl. 3 2003 S53 S55
26. S.C. Souza, H.J. Palmer, and Y.H. Kang TNF-alpha induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes J Cell Biochem 89 2003 1077 1086
27. G.I. Shulman Cellular mechanisms of insulin resistance J Clin Invest 106 2000 171 176
28. T. Nishikawa, and E. Araki Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications Antioxid Redox Signal 9 2007 343 353
29. A.M. Wassink, J.K. Olijhoek, and F.L. Visseren The metabolic syndrome: metabolic changes with vascular consequences Eur J Clin Invest 37 2007 8 17
30. J.M. Olefsky, and C.K. Glass Macrophages, inflammation, and insulin resistance Annu Rev Physiol 72 2010 219 246
31. A. Purohit, S.P. Newman, and M.J. Reed The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer Breast Cancer Res 4 2002 65 69
32. T. Wang, T.E. Rohan, and M.J. Gunter A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers Cancer Epidemiol Biomarkers Prev 20 2011 971 977
33. C. Longcope, R. Baker Jr., and C.C. Johnston Androgen and estrogen metabolism: relationship to obesity Metabolism 35 1986 235 237
34. Y. Hong, B. Yu, M. Sherman, Y.C. Yuan, D. Zhou, and S. Chen Molecular basis for the aromatization reaction and exemestane-mediated irreversible inhibition of human aromatase Mol Endocrinol 21 2007 401 414
35. T. Yamauchi, Y. Nio, and T. Maki Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions Nat Med 13 2007 332 339
36. A. Tsuchida, T. Yamauchi, and S. Takekawa Peroxisome proliferator- activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination Diabetes 54 2005 3358 3370
37. I. Rzepka-Gorska, R. Bedner, A. Cymbaluk-Ploska, and A. Chudecka-Glaz Serum adiponectin in relation to endometrial cancer and endometrial hyperplasia with atypia in obese women Eur J Gynaecol Oncol 29 2008 594 597
38. A.E. Cust, R. Kaaks, and C. Friedenreich Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women J Clin Endocrinol Metab 92 2007 255 263
39. Y. Takemura, Y. Osuga, and T. Yamauchi Expression of adiponectin receptors and its possible implication in the human endometrium Endocrinology 147 2006 3203 3210
40. L. Cong, J. Gasser, J. Zhao, B. Yang, F. Li, and A.Z. Zhao Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2 Endocr Relat Cancer 14 2007 713 720
41. F. Leyva, I.F. Godsland, and M. Ghatei Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk Arterioscler Thromb Vasc Biol 18 1998 928 933
42. E. Burgos-Ramos, J.A. Chowen, E. Arilla-Ferreiro, S. Canelles, J. Argente, and V. Barrios Chronic central leptin infusion modifies the response to acute central insulin injection by reducing the interaction of the insulin receptor with IRS2 and increasing its association with SOCS3 J Neurochem 117 2011 175 185
43. M. Sarigianni, E. Bekiari, A. Tsapas, M. Kaloyianni, G. Koliakos, and K. Paletas Effect of leptin and insulin resistance on properties of human monocytes in lean and obese healthy participants Angiology 61 2010 768 774
44. M. Sarigianni, A. Tsapas, D.P. Mikhailidis, M. Kaloyianni, G. Koliakos, and K. Paletas Involvement of signaling molecules on na/h exchanger-1 activity in human monocytes Open Cardiovasc Med J 4 2010 181 188
45. J. Gao, J. Tian, and Y. Lv Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells Cancer Sci 100 2009 389 395
46. D. Sharma, N.K. Saxena, P.M. Vertino, and F.A. Anania Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways Endocr Relat Cancer 13 2006 629 640
47. S. Catalano, C. Giordano, and P. Rizza Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation J Cell Physiol 218 2009 490 500
48. N.M. Al-Daghri, O.S. Al-Attas, M.S. Alokail, K.M. Alkharfy, and H.M. Draz Relationship between resistin and aPAI-1 levels with insulin resistance in Saudi children Pediatr Int 52 2010 551 556
49. Y.Y. Chou, W.H. Sheu, and Y.J. Tang Plasminogen activator inhibitor type 1 (PAI-1) is a valuable biomarker for predicting the metabolic syndrome (MS) in institutionalized elderly residents in Taiwan Arch Gerontol Geriatr 49 Suppl. 2 2009 S41 S45
50. C. Tecimer, D.L. Doering, L.J. Goldsmith, J.S. Meyer, G. Abdulhay, and J.L. Wittliff Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endometrial cancer Gynecol Oncol 80 2001 48 55
51. M. Fredstorp-Lidebring, P.O. Bendahl, and N. Brunner Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer Eur J Cancer 37 2001 2339 2348
52. Z. Suba Interplay between insulin resistance and estrogen deficiency as co- activators in carcinogenesis Pathol Oncol Res 18 2011 123 133
53. N.D. Freedman, J.J. Lacey, A.R. Hollenbeck, M.F. Leitzmann, A. Schatzkin, and C.C. Abnet The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH-AARP cohort Cancer 116 2010 1572 1581
54. K. Britt, A. Ashworth, and M. Smalley Pregnancy and the risk of breast cancer Endocr Relat Cancer 14 2007 907 933
55. G.L. Anderson, M. Limacher, and A.R. Assaf Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial JAMA 291 2004 1701 1712
56. Z. Suba Gender-related hormonal risk factors for oral cancer Pathol Oncol Res 13 2007 195 202
57. M.E. Jones, A.W. Thorburn, and K.L. Britt Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity Proc Natl Acad Sci USA 97 2000 12735 12740
58. C.G. Solomon, F.B. Hu, and A. Dunaif Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus JAMA 286 2001 2421 2426
59. A.J. Proudler, C.V. Felton, and J.C. Stevenson Ageing and the response of plasma insulin, glucose and C-peptide concentrations to intravenous glucose in postmenopausal women Clin Sci (Lond) 83 1992 489 494
60. J. Zhao, F.X. Xue, S.F. Hua, and L.Z. Zhang Effects of insulin on proliferation and apoptosis of endometrial carcinoma cell Zhonghua Fu Chan Ke Za Zhi 42 2007 696 700
61. M. Funaki, H. Katagiri, K. Inukai, M. Kikuchi, and T. Asano Structure and function of phosphatidylinositol-3,4 kinase Cell Signal 12 2000 135 142
62. R.J. Davis The mitogen-activated protein kinase signal transduction pathway J Biol Chem 268 1993 14553 14556
63. K. Mussig, and H.U. Haring Insulin signal transduction in normal cells and its role in carcinogenesis Exp Clin Endocrinol Diabetes 118 2010 356 359
64. K. Ogawa, C. Sun, and A. Horii Exploration of genetic alterations in human endometrial cancer and melanoma: distinct tumorigenic pathways that share a frequent abnormal PI3K/AKT cascade Oncol Rep 14 2005 1481 1485
65. H.B. Salvesen, S.L. Carter, and M. Mannelqvist Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation Proc Natl Acad Sci USA 106 2009 4834 4839
66. M.A. Lawlor, and D.R. Alessi PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114 2001 2903 2910
67. A. Dellas, G. Jundt, G. Sartorius, M. Schneider, and H. Moch Combined PTEN and p27kip1 protein expression patterns are associated with obesity and prognosis in endometrial carcinomas Clin Cancer Res 15 2009 2456 2462
68. S. Horman, D. Vertommen, and R. Heath Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491 J Biol Chem 281 2006 5335 5340
69. K. Inoki, T. Zhu, and K.L. Guan TSC2 mediates cellular energy response to control cell growth and survival Cell 115 2003 577 590
70. D.M. Gwinn, D.B. Shackelford, and D.F. Egan AMPK phosphorylation of raptor mediates a metabolic checkpoint Mol Cell 30 2008 214 226
71. K.H. Lu, W. Wu, and B. Dave Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma Clin Cancer Res 14 2008 2543 2550
72. H. Kashima, T. Shiozawa, and T. Miyamoto Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E Endocr Relat Cancer 16 2009 113 122
73. Z. Ai, L. Yin, and X. Zhou Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer Cancer 107 2006 746 756
74. E.M. Bailyes, B.T. Nave, M.A. Soos, S.R. Orr, A.C. Hayward, and K. Siddle Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting Biochem J 327 Pt 1 1997 209 215
75. M.N. Pollak, E.S. Schernhammer, and S.E. Hankinson Insulin-like growth factors and neoplasia Nat Rev Cancer 4 2004 505 518
76. S. Kato, Y. Masuhiro, and M. Watanabe Molecular mechanism of a cross-talk between oestrogen and growth factor signalling pathways Genes Cells 5 2000 593 601
77. R.B. Lathi, A.P. Hess, S. Tulac, N.R. Nayak, M. Conti, and L.C. Giudice Dose-dependent insulin regulation of insulin-like growth factor binding protein-1 in human endometrial stromal cells is mediated by distinct signaling pathways J Clin Endocrinol Metab 90 2005 1599 1606
78. D.H. Fagan, and D. Yee Crosstalk between IGF1R and estrogen receptor signaling in breast cancer J Mammary Gland Biol Neoplasia 13 2008 423 429
79. T.J. Key, P.N. Appleby, G.K. Reeves, and A.W. Roddam Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies Lancet Oncol 11 2010 530 542
80. J.V. Lacey Jr., N. Potischman, and M.P. Madigan Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study Cancer Epidemiol Biomarkers Prev 13 2004 607 612
81. E. Petridou, P. Koukoulomatis, D.M. Alexe, Z. Voulgaris, E. Spanos, and D. Trichopoulos Endometrial cancer and the IGF system: a case-control study in Greece Oncology 64 2003 341 345
82. L.S. Augustin, L. Dal Maso, and S. Franceschi Association between components of the insulin-like growth factor system and endometrial cancer risk Oncology 67 2004 54 59
83. B. Waksmanski, J. Dudkiewicz, and S. Dabrowski Function of insulin-like growth factor (IGF-I) and its binding protein (IGFBP-1) in pathological proliferation of endometrium Wiad Lek 54 2001 656 661
84. S.R. Plymate, L.A. Matej, R.E. Jones, and K.E. Friedl Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin J Clin Endocrinol Metab 67 1988 460 464
85. L. Baglietto, D.R. English, and J.L. Hopper Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition Breast Cancer Res Treat 115 2009 171 179
86. A. Vermeulen, and L. Verdonck Sex hormone concentrations in post-menopausal women Clin Endocrinol (Oxf) 9 1978 59 66
87. E. Diamanti-Kandarakis, J. Papailiou, and S. Palimeri Hyperandrogenemia: pathophysiology and its role in ovulatory dysfunction in PCOS Pediatr Endocrinol Rev 3 Suppl. 1 2006 198 204
88. R. Navaratnarajah, O.C. Pillay, and P. Hardiman Polycystic ovary syndrome and endometrial cancer Semin Reprod Med 26 2008 62 71
89. L. Li, C. Yang, and Qiaojie Pathological and immunohistochemical study on estrogen and progesterone receptors in endometrium of polycystic ovarian syndrome Zhonghua Fu Chan Ke Za Zhi 33 1998 89 91
90. M. Gibson Reproductive health and polycystic ovary syndrome Am J Med 98 1995 67S 75S
91. D. Meirow, and J.G. Schenker The link between female infertility and cancer: epidemiology and possible aetiologies Hum Reprod Update 2 1996 63 75
92. C. Weyer, T. Funahashi, and S. Tanaka Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia J Clin Endocrinol Metab 86 2001 1930 1935
93. M. Tajtakova, D. Petrasova, A. Pidanicova, A. Gallovicova, C. Blanarova, and J. Petrovicova Serum levels of leptin, adiponectin, retinol binding protein 4 and leptin/adiponectin molar ratio as another possible marker of insulin resistance in obese Bratisl Lek Listy 111 2010 212 215
94. P.T. Soliman, D. Wu, and G. Tortolero-Luna Association between adiponectin, insulin resistance, and endometrial cancer Cancer 106 2006 2376 2381
95. E. Petridou, C. Mantzoros, and N. Dessypris Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece J Clin Endocrinol Metab 88 2003 993 997
96. L. Dal Maso, L.S. Augustin, and A. Karalis Circulating adiponectin and endometrial cancer risk J Clin Endocrinol Metab 89 2004 1160 1163
97. A.E. Cust, N.E. Allen, and S. Rinaldi Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition Int J Cancer 120 2007 2656 2664
98. R. Troisi, N. Potischman, R.N. Hoover, P. Siiteri, and L.A. Brinton Insulin and endometrial cancer Am J Epidemiol 146 1997 476 482
99. G. Schimmack, R.A. Defronzo, and N. Musi AMP-activated protein kinase: role in metabolism and therapeutic implications Diabetes Obes Metab 8 2006 591 602
100. T.V. Kourelis, and R.D. Siegel Metformin and cancer: new applications for an old drug Med Oncol 2011 [Epub ahead of print, PMID:21301998]
101. A.M. Gonzalez-Angulo, and F. Meric-Bernstam Metformin: a therapeutic opportunity in breast cancer Clin Cancer Res 16 2010 1695 1700
102. L.A. Cantrell, C. Zhou, A. Mendivil, K.M. Malloy, P.A. Gehrig, and V.L. Bae-Jump Metformin is a potent inhibitor of endometrial cancer cell proliferation - implications for a novel treatment strategy Gynecol Oncol 116 2010 92 98
103. D.R. Session, K.R. Kalli, I.S. Tummon, M.A. Damario, and D.A. Dumesic Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent Gynecol Endocrinol 17 2003 405 407
104. S. Stanosz An attempt at conservative treatment in selected cases of type I endometrial carcinoma (stage I a/G1) in young women Eur J Gynaecol Oncol 30 2009 365 369
105. N. Mu, Y. Wang, and F. Xue Metformin: a potential novel endometrial cancer therapy Int J Gynecol Cancer 22 2012 181
106. Y.X. Yang, S. Hennessy, and J.D. Lewis Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients Gastroenterology 127 2004 1044 1050
107. Y.W. Chung, D.S. Han, K.H. Park, C.S. Eun, K.S. Yoo, and C.K. Park Insulin therapy and colorectal adenoma risk among patients with type 2 diabetes mellitus: a case-control study in Korea Dis Colon Rectum 51 2008 593 597